Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 9
2004 1
2005 6
2006 3
2007 3
2008 3
2009 7
2010 6
2011 3
2012 5
2013 9
2014 7
2015 7
2016 9
2017 2
2018 7
2019 8
2020 3
2021 6
2022 10
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Efficient Augmented Intelligence Framework for Bladder Lesion Detection.
Eminaga O, Lee TJ, Laurie M, Ge TJ, La V, Long J, Semjonow A, Bogemann M, Lau H, Shkolyar E, Xing L, Liao JC. Eminaga O, et al. Among authors: semjonow a. JCO Clin Cancer Inform. 2023 Sep;7:e2300031. doi: 10.1200/CCI.23.00031. JCO Clin Cancer Inform. 2023. PMID: 37774313 Free article.
Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort.
Marenghi C, Qiu Z, Helleman J, Nieboer D, Rubio-Briones J, Carroll PR, Lee LS, Valdagni R, Boutros PC, Nicolai N; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Marenghi C, et al. Cancers (Basel). 2022 Jul 22;14(15):3558. doi: 10.3390/cancers14153558. Cancers (Basel). 2022. PMID: 35892817 Free PMC article.
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.
Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM, Gnanapragasam V, Shiong Lee L, Elhage O, Klotz L, Carroll P, Pickles T, Bjartell A, Robert G, Frydenberg M, Sugimoto M, Ehdaie B, Morgan TM, Rubio-Briones J, Semjonow A, Bangma CH, Roobol MJ; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Remmers S, et al. Among authors: semjonow a. Eur Urol Open Sci. 2022 Jun 14;41:126-133. doi: 10.1016/j.euros.2022.05.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35813247 Free PMC article.
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer.
Besler K, Węglarz A, Keller L, von Amsberg G, Bednarz-Knoll N, Offermann A, Stoupiec S, Eltze E, Semjonow A, Boettcher L, Schneegans S, Perner S, Hauch S, Todenhöfer T, Peine S, Pantel K, Wikman H, Werner S. Besler K, et al. Among authors: semjonow a. Clin Chem. 2022 Jul 3;68(7):973-983. doi: 10.1093/clinchem/hvac073. Clin Chem. 2022. PMID: 35652463
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study.
Luiting HB, Remmers S, Boevé ER, Valdagni R, Chiu PK, Semjonow A, Berge V, Tully KH, Rannikko AS, Staerman F, Roobol MJ. Luiting HB, et al. Among authors: semjonow a. Eur Urol Oncol. 2022 Dec;5(6):651-658. doi: 10.1016/j.euo.2022.03.007. Epub 2022 Apr 15. Eur Urol Oncol. 2022. PMID: 35437217 Free article.
104 results